Jae Yeon Jung MD MD, PhD

PubMed

• 5 citations
  Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors.
  Alexander S Bang, Milan J Anadkat, Jennifer N Choi, Nicole R LeBoeuf, Jae Y Jung
  American Journal of Clinical Dermatology. 2022-07-01
• 12 citations
  Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region.
  Milan J Anadkat, Mario Lacouture, Adam Friedman, Zachary D Horne, Jae Jung
  Frontiers in Oncology. 2022-01-01
• 28 citations
  IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
  Dulce M. Barrios, Gregory S. Phillips, Amaris Geisler, Sabrina Trelles, Alina Markova
  Annals of Oncology. 2021-06-01

Journal Articles

• Survivin promotion of melanoma metastasis requires upregulation of integrin alpha 5 integrin  
  Mackenzie J, Liu T, Jung J, Jones B, Welm A, Grossman D, Carcinogenesis, 9/1/2013
• Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis  
  Ririe MR1, Blaylock RC, Morris SE, Jung J, J Am Acad Dermatol, 8/1/2013
• Familial Melanoma-Associated Mutations in p16 Uncouple its Tumor-Suppressor Functions  
  Jenkins NC, Jung J, Liu T, Wilde M, Holmen SL, Grossman D, J Invest Dermatol, 4/1/2013
• Pseudomonas aeruginosa infection results in cholesteatomas with greater morbidity in a gerbil model  
  Jung J, Wang E, Lee D, Nason R, Chole R, Laryngoscope, 11/1/2011
• Lymphomatoid drug reaction to Ustekinumab  
  Jung J, Levin E, Jarrett R, Liu D, Mann C, Archives of Dermatology, 8/1/2011
• Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis  
  Nason R, Jung J, Chole R, J Assoc Res Otolaryngol, 6/1/2009
• Radiographic and micro-computed tomographic imaging of lipopolysaccharide-mediated bone resorption  
  Nason R, Lee D, Jung J, Chole R, Ann Otol Rhinol Laryngol, 5/1/2009
• Tumor immunotherapy by epicutaneous immunization requires langerhans cells  
  Stoitzner P, Green L, Jung J, Price K, Tripp C, Malissen B, Kissenpfennig A, Hermans I, Ronchese F, J Immunology, 2/1/2008
• Inefficient presentation of tumor-derived antigen by tumor infiltrating dendritic cells  
  Stoitzner P, Green L, Jung J, Price K, Atarea H, Kivell B, Ronchese F, Cancer Immunol Immunother, 1/1/2008
• Pseudomoas aeruginosa LPS induces osteoclastogenesis through a TLR4 mediated pathway in vivo and in vitro  
  Zhuang L, Jung J, Wang E, Ramos L, Houlihan S, Pashia M, Chole R, Laryngoscope, 5/1/2007
• Characterization of otopathogenic Pseudomonas aeruginosa: a biofilm phenotype  
  Wang E, Jung J, Nason R, Pashia M, Chole R, Arch Otolaryngol Head Neck Surg, 11/1/2005
• A murine model of cholesteatoma-induced bone resorption using autologous dermal implantation  
  Sudhoff H, Liebehenz Y, Aschenbrenner J, Jung J, Hildmann H, Dazert S, Laryngoscope, 6/1/2003
• Bone resorption in chronic otitis media: the role of the osteoclast Review  
  Jung J, Chole R, ORL J Otorhinolaryngol Relat Spec, 3/1/2002
• Join now to see all

Abstracts/Posters

• Pseudomonas aeruginosa adhesion and cytotoxicity in keratinocytes and A549 pulmonary epithelial cells.
  Jung J, Wang E, Sinwell T, Cornelius L, Chole R, Society for Investigative Dermatology 69th Annual Meeting, Montreal, Canada, 1/1/2009
• Pseudomonas aeruginosa adhesion and invasion of human keratinocytes.
  Jung J, Nason R, Wang E, Pashia M, Cornelius L, Chole R, Society for Investigative Dermatology 66th Annual Meeting, St. Louis, MO, 1/1/2005
• Otopathogenic Pseudomonas aeruginosa exhibits biofilm-forming characteristics: initial observations.
  Wang E, Pashia M, Jung J, Chole R, 8th International Symposium on Recent Advances in Otitis Media, Ft. Lauderdale, FL, 1/1/2003

Lectures

• Side Effects May Include: Illustrative Cases of Dermatologic Adverse Events 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
• Dermatologic Reactions and Grading. 
  Memorial Sloan Kettering, New York, NY - 1/1/2013
• Dermatologic Complications of BMT and Immunosuppression in Cancer Patients. 
  Duarte, CA - 1/1/2013
• Common Dermatoses in Cancer Patients. 
  City of Hope, Duarte, CA - 1/1/2013
• Graft versus Host disease. 
  City of Hope, Duarte, CA - 1/1/2012
• Toward a standard protocol: treatment options for Stevens-Johnson syndrome and toxic epidermal necrolysis. 
  Salt Lake City, UT - 1/1/2012
• IVIG for the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis. 
  1/1/2012
• A murine model of melanoma immunotherapy by epicutaneous immunization. 
  Salt Lake City, UT - 1/1/2011
• Birt-Hogg-Dube Syndrome. 
  St. Louis, MO - 1/1/2010
• Join now to see all